Insider Transactions in Q2 2023 at Rhythm Pharmaceuticals, Inc. (RYTM)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2023
|
Hunter C Smith Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+3.15%
|
$12,000
$6.88 P/Share
|